|
HY-P4076-1mg
|
MedChemexpress LLC
|
MPG peptides, PBeta [CAS 791642-10-9]
|
|
|
|
|
HY-P4076-10mg
|
MedChemexpress LLC
|
MPG peptides, PBeta [CAS 791642-10-9]
|
|
|
|
|
HY-P4076-5mg
|
MedChemexpress LLC
|
MPG peptides, PBeta [CAS 791642-10-9]
|
|
|
|
|
HY-P80229-10uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
|
HY-P80229-100uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
|
HY-P80229-50uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
|
HY-P80758-10uL
|
MedChemexpress LLC
|
MSR1 Antibody
|
|
|
|
|
HY-P80758-100uL
|
MedChemexpress LLC
|
MSR1 Antibody
|
|
|
|
|
HY-P80758-50uL
|
MedChemexpress LLC
|
MSR1 Antibody
|
|
|
|
|
HY-P80230-10uL
|
MedChemexpress LLC
|
Mst2 Antibody
|
|
|
|
|
HY-P80230-100uL
|
MedChemexpress LLC
|
Mst2 Antibody
|
|
|
|
|
HY-P80230-50uL
|
MedChemexpress LLC
|
Mst2 Antibody
|
|
|
|
|
HY-153832-10mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-100mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-25mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-5mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-50mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-P80759-10uL
|
MedChemexpress LLC
|
mTOR Antibody
|
|
|
|
|
HY-P80759-100uL
|
MedChemexpress LLC
|
mTOR Antibody
|
|
|
|
|
HY-P80759-50uL
|
MedChemexpress LLC
|
mTOR Antibody
|
|
|
|
|
HY-P80231-10uL
|
MedChemexpress LLC
|
mTOR Antibody (YA281)
|
|
|
|
|
HY-P80231-100uL
|
MedChemexpress LLC
|
mTOR Antibody (YA281)
|
|
|
|
|
HY-P80231-50uL
|
MedChemexpress LLC
|
mTOR Antibody (YA281)
|
|
|
|
|
HY-P71712-20ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse (P.pastoris, His)
|
|
|
|
|
HY-P71712-50ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse (P.pastoris, His)
|
|
|
|
